Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacy.

Two open, phase II studies were performed to evaluate the activity and toxicity of infusional topotecan in patients with advanced non-small-cell lung carcinoma (NSCLC) and advanced breast cancer who had not received previous chemotherapy for metastatic disease. Twenty-five patients with an ECOG perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Mainwaring, P. N., Nicolson, M. C., Hickish, T., Penson, R., Joel, S., Slevin, M., Smith, I. E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228211/
https://www.ncbi.nlm.nih.gov/pubmed/9413954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228211/
https://www.ncbi.nlm.nih.gov/pubmed/9413954

Ejemplares similares